Anavex Life Sciences Corp.
AVXL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001314052
No open-market purchases or sales by Anavex Life Sciences Corp. insiders were filed in the last 90 days; 180 institutions reported holding it in 13F filings for Q2 2026, worth $95.8M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Anavex Life Sciences Corp. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 148 | 2 | 139 | −7 |
| Shares | 24.4M | 6.24K | 27.0M | +2.62M (+10.8%) |
| Value | $251.4M | $64.0K | $248.7M | −$2.58M (−1.0%) |
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held Anavex Life Sciences Corp. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Prosperity Financial Group, Inc. | 47,963 | $444.1K | 0.48% |
| XTX Topco Ltd | 38,287 | $354.5K | 0.08% |
| Marshall Wace, LLP | 34,996 | $324.1K | 0.00% |
| Tudor Investment Corp Et Al | 34,350 | $318.0K | 0.01% |
| Virtu Financial LLC | 29,614 | $274.0K | 0.04% |
| Carnegie Capital Asset Management, LLC | 18,750 | $173.6K | 0.01% |
| Quantamental Technologies LLC | 18,534 | $171.6K | 0.08% |
| Gladstone Institutional Advisory LLC | 18,160 | $168.2K | 0.01% |
| Miracle Mile Advisors, LLC | 10,547 | $97.7K | 0.00% |
| Advisory Services Network, LLC | 4,950 | $45.8K | 0.00% |
| Cutler Group LP | 1,500 | $13.0K | 0.00% |
| Fiduciary Alliance LLC | 1,092 | $10.1K | 0.00% |
| Oliver Lagore Vanvalin Investment Group | 770 | $7.13K | 0.00% |
| Grey Fox Wealth Advisors, LLC | 300 | $2.78K | 0.00% |
| Richard W. Paul & Associates, LLC | 295 | $2.73K | 0.00% |
| Colonial Trust Advisors | 200 | $1.85K | 0.00% |
| GWM Advisors LLC | 140 | $1.30K | 0.00% |
| CWM, LLC | 86 | $1.00K | 0.00% |
Sold out (25)
Institutions that held Anavex Life Sciences Corp. at the end of Q3 2022 and filed for Q4 2022 without it.
Not filed for Q4 2022 yet (2)
Institutions that held Anavex Life Sciences Corp. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| American Portfolios Advisors | 6,100 | $63.0K |
| Wipfli Financial Advisors LLC, | 137 | $1.00K |